Dopamine transporter single photon emission computed tomography (DaTscan) and metaiodobenzylguanidine (MIBG) myocardial scintigraphy help assess neuronal loss in Lewy body diseases. This evidence concerns the gene SLC6A3 and Lewy body dementia.